California utility PG&E vows more power shutdowns to prevent wildfire
California utility PG&E Corp plans to increase the controversial practice of shutting off the power to communities at risk of wildfire when dangerous conditions such as high winds and dry heat are present.
GM Cruise chief could earn $25 million in long-term incentives
The head of General Motors Co’s Cruise self-driving car unit stands to make more than $25 million over the next decade if the technology subsidiary experiences a change in ownership or is listed publicly, according to a regulatory filing on Wednesday.
Qantas cancels order for 8 Airbus A380s amid doubts on jet’s future
Australia’s Qantas Airways Ltd said on Thursday it formally canceled a longstanding order for eight Airbus SE A380 superjumbo jets.
SoftBank shares soar 13 percent after $5.5 billion share buyback news
SoftBank Group Corp shares jumped 13 percent on Thursday, a day after Chief Executive Masayoshi Son unveiled a $5.5 billion share buyback to prop up its share price, which he sees as undervalued.
Asian shares doze in data lull, New Zealand dollar takes a dive
Asian share markets were in a muted mood on Thursday and looked set for a sleepy session with China still on holiday and no major economic data on the diary.
Weak U.S. profit picture may not be so bad: Credit Suisse
As some market watchers brace for a potential U.S. earnings recession this year, one prominent equity strategist says the picture is not as bad as feared.
GM Cruise chief stands to earn $179 million in incentives: SEC filing
The head of General Motors Co’s Cruise self-driving car unit stands to make more than $179 million over the next decade if the technology subsidiary experiences a change in ownership or is listed publicly, according to a regulatory filing on Wednesday….
Chipotle’s fresh food campaign drives profit beat, shares surge
Chipotle Mexican Grill Inc topped Wall Street forecasts for quarterly earnings as aggressive marketing helped lure more diners and boost online orders, sending its shares up 10 percent in after-hours trading on Wednesday.
At least four pharma CEOs to testify at Senate drug pricing hearing
Drugmakers Pfizer Inc, Bristol-Myers Squibb Co and Sanofi SA said on Wednesday that their chief executives plan to testify at a Senate hearing on rising prescription drug prices later this month.
Novartis CEO says U.S. rebate plan will return cash to patients
Novartis AG Chief Executive Vas Narasimhan said his company’s prescription drug prices have been “flat to negative” over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.
